# FDA recall D-1229-2014

> **Glenmark Generics Inc., USA** · Class II · drug recall initiated 2014-03-18.

## Product

Ranitidine Tablets USP, 150 mg, 500-count bottles, Rx only, Manufactured by: Shasun Pharmaceuticals Limited, Unit-II R.S. No 32 33 & 34, Shasun Road, Periyakalapet, Puducherry, - 605 014, India; Manufactured for: Glenmark Generics Inc, USA, Mahwah, NJ 07430, UPC 3 68462 24805 8, NDC 68462-248-05.

## Reason for recall

Presence of Foreign Tablets/Capsules: Recall is due to a pharmacist complaint of a "foreign material", identified as Metoprolol Tartrate Tablet USP 50 mg, found co-mingled in a bottle of Ranitidine Tablets USP 150 mg.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1229-2014
- **Recalling firm:** Glenmark Generics Inc., USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-03-18
- **Report date:** 2014-04-16
- **Termination date:** 2015-01-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Mahwah, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1229-2014

## Citation

> AI Analytics. FDA recall D-1229-2014. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-1229-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*